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Objective: To test the hypothesis that oral administration of 24% sucrose associated with 
 nonnutritive sucking in healthy newborns receiving venipuncture beyond the first week of life con-
trols pain and pain-related variation in heart rate (HR) and noninvasive oxygen saturation (SpO
2
).
Methods: A total of 66 term newborns were enrolled between February and September 2017 
in the Neonatology Department of AORN Santobono-Pausilipon, Naples. They were randomly 
assigned to receive oral 1 mL 24% sucrose (treated group [TG], n=33; gestational age 38.53±1.49 
weeks; body weight 3,035±55 g; age 22.40±6.82 weeks) or oral 1 mL 10% glucose (control 
group [CG], n=33; gestational age 38.91±1.45 weeks; body weight 3,203±65 g; age 23.36±7.02 
weeks) 1 minute before and during venipuncture. Evaluations were carried out between 8 and 9 
am in all newborns. The Neonatal Infant Pain Scale (NIPS) was used to assess pain in newborns. 
Outcome measurements (HR, SpO
2
) were obtained before (T0), during (T1), and 1 minute after 
(T2) venipuncture using a Nellcor bedside SpO
2
 patient-monitoring system. NIPS scores were 
recorded throughout the procedure. Statistical analysis was performed using SPSS version 20.0. 
Changes in HR and SpO
2
 were assessed by mixed ANOVA for repeated measures. NIPS scores 
were evaluated by Mann–Whitney U test.
Results: There were no statistically significant differences in HR or SpO
2
 between TG and CG 
at T0. HR was significantly lower in TG than CG at both T1 and T2 (P<0.05), whereas SpO
2
 was 
significantly higher in TG than CG at both T1 and T2 (P<0.05). NIPS scores were significantly 
lower in TG (median 0) than CG (median 6) during the entire procedure (P<0.05).
Conclusion: Oral administration of 24% sucrose associated with nonnutritive sucking prior to 
and during a painful procedure has a strong impact on pain response in term newborns, reducing 
NIPS scores and influencing pain-associated variations in HR and SpO
2
. Complete analgesia 
during painful procedures in term newborns might prevent pain reactivity and its behavioral 
and neurodevelopmental consequences. Replication of this study is needed before widespread 
application of findings.
Keywords: oral sucrose, heart rate, neonatal pain
Introduction
A widely accepted definition of pain was developed by a taxonomy task force of the 
International Association for the Study of Pain: “Pain is an unpleasant sensory and 
emotional experience that is associated with actual or potential tissue damage or 
described in such terms.” A key feature of this definition is “pain is always subjec-
tive”. Pain management in neonates should not just be driven by ethics or empathy, 
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but should be viewed as part of normal medical and nursing 
care.1 Noxious stimulation in the form of venipuncture or heel 
prick produces a cortical response in both preterm and term 
newborn infants, measured as an increase in total hemoglobin 
concentration in the contralateral somatosensory cortex, and 
nociceptive reflexes, measurable as lower-limb withdrawal 
and flexor-muscle activity.2 Pain is a particular problem for 
newborns: early in life, it elicits specific behaviors, activates 
the somatosensory cortex, and stimulates neuroendocrine 
stress responses, thus leading to short- and long-term clini-
cal consequences.1–4
Studies have demonstrated a relationship between pain 
degree and oxidative stress in healthy full-term newborns at 
their first pain exposure. We have also reported that senso-
rial saturation reduces pain score together with pain-related 
oxidative stress.5 Sensorial saturation is a technique used 
during heel prick in which mothers simultaneously attract 
their infant’s attention by massaging the cheek, speaking to 
the baby gently, and administering oral glucose.6
Multiple trials and systematic reviews have highlighted 
beneficial analgesic effects of 24% sucrose for neonates 
undergoing invasive procedures.7–10 Sucrose in combination 
with other nonpharmacological interventions, such as nonnu-
tritive sucking (NNS) seems to be more effective than sucrose 
alone.10 Nevertheless, there is limited evidence regarding 
its analgesic efficacy and safety in healthy term newborns 
beyond the first week of life. In this comparative study, 
we tested the hypothesis that oral administration of 24% 
sucrose associated with NNS in healthy newborns receiving 
venipuncture beyond the first week of life controls pain and 
pain-associated variation of heart rate (HR) and noninvasive 
oxygen saturation (SpO
2
) better that oral administration of 
10% glucose associated with NNS.
Methods
Participants
A randomized double-blinded case–control pilot study was 
conducted from February to September 2017 at the neonatal 
intensive care unit (NICU) of Santobono-Pausilipon Hospi-
tal in Naples, Italy, following research-ethics approval and 
written informed consent from the families. The study was 
conducted in accordance with the Declaration of Helsinki. 
Inclusion criteria were Italian neonates 37–42 weeks gesta-
tional age at birth and >1 week old at the time of the interven-
tion with body weight 2,500–4,500 g and able to feed orally. 
Exclusion criteria were concurrent use of pharmacological 
pain strategies, neonates with a contraindication for sucrose 
administration (eg, too ill or unstable for neonatologist 
 assessment, unable to swallow, pharmacologically muscle-
relaxed), and inability to assess behavioral responses to pain 
accurately (eg, neonate’s face blocked with tape). Patients 
undergoing painful, stressful procedures or with congenital 
or perinatal diseases were excluded. Patients born from 
smoking mothers and those with maternal diabetes, placenta 
abruption, chronic pathologies, or using drugs/alcohol dur-
ing pregnancy and infants with fetal growth restriction, fetal 
malformations, genetic/metabolic disorders, clinical signs of 
maternal, or fetal infection were also excluded (Figure 1).
Newborns were enrolled after their first week of life dur-
ing routine control for hyperbilirubinemia or minor surgery 
in the neonatology ward. Routine controls were carried out 
in a separate room with 2,000 lx between 9 and 10 am.11 
Another room was used for the treatment intervention and 
projected to reduce sources of stress, with instrument noise 
set at <45 dB and 10–600 lx.12
Newborns were randomly assigned to receive oral sucrose 
and NNS (treated group ([TG]) or comprised the control 
group (CG), and randomization was performed using a 
privacy-protected randomization hospital service. In the TG, 
each infant received both 1 mL 24% sucrose (Antalbimbo; 
Orsana, Rome, Italy) orally via syringe 1 minute before 
venipuncture and 1 mL during the procedure. A pacifier 
was offered to all neonates immediately following sucrose 
administration to facilitate NNS, which has been shown to 
enhance efficacy.10 In the CG, each infant received 1 mL 10% 
glucose orally via syringe with a pacifier 1 minute before 
venipuncture and during the procedure. Oral solutions were 
administered drop by drop by an expert caregiver via syringe 
over the anterior surface of the tongue, allowing for individual 
neonate swallowing rates over a period of 1 minute. Outcome 
measures (HR, SpO
2
, Neonatal Infant Pain Scale [NIPS]) 
were obtained prior to (T0), during (T1), and 1 minute after 
venipuncture (T2) in each group. Neonate behavior was 
scored using the NIPS. Investigators and caregivers were 
blinded to group assignment.
Instruments
Data were recorded using a database (Excel 2007) by a 
pediatric nurse who was aware of the study aims. Param-
eters collected were sex, gestational age, days of life, body 
weight, HR at T0, T1, and T2, SpO
2
 at T0, T1, and T2, and 
NIPS scores at T1.
Another pediatric nurse aware of the study aims measured 
the body weight of the newborns with a Seca 354 baby scale 
and collected NIPS scores after 6 months of NIPS practice. 
Vital parameters were collected with a Nellcor bedside SpO
2
 
Journal of Pain Research 2019:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
301
Sucrose 24% by nonnutritive sucking for pain control in newborns
patient-monitoring system. The research nurse placed pulse 
oximetry probes on the right wrist of every neonate to record 
HR and SpO
2
 continuously and positioned herself in front of 
the newborn to capture facial movements.
Outcome measures
The primary outcome was pain intensity measured with 
the NIPS, a behavioral scale validated by Lawrence et al 
in 199313 that comprises six items (facial expression, cry, 
breathing, arms, legs, and state of arousal). Caregivers can 
rate items from 0 (relaxed) to 1 (different than basal) and 
from 0 (absent) to 2 (vigorous) for cry. A score ≥4 indicates 
that the newborn feels pain.
The secondary outcome was frequency of a priori-speci-
fied adverse event/tolerance criteria (HR >240 beats/minute 
or HR <80 beats/minute for >20 seconds, SpO
2
 <80% for 
>20 seconds, no spontaneous respirations for >20 seconds, 
and choking/gagging). Adverse-event data were collected 
by the research nurse during the intervention, and she also 
kept a record of “rescue doses” administered (ie, additional 
doses of sucrose or glucose) if the neonate became overly 
distressed during the procedure.
Statistical analysis
Statistical analysis was performed by a statistician who 
was aware of the study aim using SPSS version 20.0 (IBM, 
Armonk, NY, USA). Normal distribution of the data was 
evaluated by Kolmogorov–Smirnov test. Parametric and 
nonparametric data were evaluated by one-way ANOVA or 
c2 test, respectively. Changes in HR and SpO
2
 from T0 to 
T2 were assessed by mixed ANOVA for repeated measures. 
HR and SpO
2
 were analyzed by reciprocal transformation 
because of lack of homogeneity. Differences between NIPS 
scores were evaluated by Mann–Whitney U test. All data 
with P<0.05 were considered significant.
Results
A total of 66 term newborns were enrolled for the study 
and randomly assigned to each group (33 in CG and 33 in 
TG). Demographic characteristics in the two groups were 
matched and comparable (Table 1). The groups started from 
similar conditions for HR and SpO
2
 at T0 (Table 2). Changes 
in vital parameters between groups are reported in Table 2 
and  Figures 2–4. NIPS scores in both groups were <4 at 
T0; however, scores were significantly lower in TG (range 
Figure 1 Enrollment flowchart.
120 newborns met the
inclusion criteria
66 newborns
underwent
randomization
33 newborns were
randomly assigned to
receive oral sucrose
33 newborns were
randomly assigned to
receive oral glucose
54 met the exclusion criteria:
13 had a late-onset sepsis
7 had inherited disorders
20 were born from smoking mothers
5 were born from placenta abruption
9 were sedated with pharmacologic
pain strategies
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1–2 and median 0) compared with CG at T1 (range 5–7 
and median 6). Finally, 100% of term newborns in CG had 
a score ≥4 (range 4–6 and median 5) and 100% of those in 
TG showed a score <4 at T2 (range and median 0). There 
were no reported adverse events defined by a priori criteria 
among neonates.
Table 1 Clinical characteristics of study population
Clinical characteristics Treated  
(n=33)
Controls  
(n=33)
P-value
Sexa Male 72% Male 67% 0.592
Gestational age (weeks) 38.53±1.49 38.91±1.45 0.309
Body weight at birth (g) 3.035±0.55 3.203±0.65 0.267
Days of life 22.40±6.82 23.36±7.02 0.820
Heart rate, T0 143±16.8 147±12.5 0.181
SpO2, T0 99.48±0.56 99.57±0.61 0.538
Notes: Data expressed as mean±SD. aPercentages reported for nominal data.
Table 2 Change in vital parameters from T0 (before) to T2 (after venipuncture)
Vital 
parameters
Time n Control group Treated 
group
F(1,60) P-value R-value
Heart rate
T0 vs T1 T0 29 143±16.8 147±12.5 69.572 <0.05 0.73
T1 33 191.57±16.94 159.48±12.46
T1 vs T2 T1 33 191.57±16.94 159.48±12.46 16.312 <0.05 0.46
T2 33 160.51±17.65 147.42±12.05
SpO2
T0 vs T1 T0 33 99.48±0.56 99.57±0.61 215.443 <0.05 0.88
T1 33 89.93±4.11 98.39±0.89
T1 vs T2 T1 33 89.93±4.11 98.39±0.89 47.629 <0.05 0.66
T2 29 97.39±1.05 99.51±0.62
Notes: Data expressed as mean±SD.
Discussion
In this study, we report that oral administration of 1 mL 
24% sucrose prior to and during a single painful procedure 
appears to be effective in significantly reducing pain in term 
neonates at the first experience of procedural pain beyond the 
first week of life. As we know, inadequate pain management 
in neonatal life is a major impediment to proper neurodevel-
opment: it alters pain thresholds, physiological responses, 
and stress- or pain-related behavior beyond early infancy.14 
Nonpharmacological pain control for infants has been 
recently supported. Although the impacts of nonpharmaco-
logical interventions have been assessed extensively, they 
were evaluated mostly in sick babies of different postnatal 
ages using different treatments and pain assessments that 
yielded ununiform data. Rioualen et al compared sucrose 
solution or breast-feeding before venipuncture for neonatal 
screening in healthy 3-day-old term neonates.15 They used 
Figure 2 Heart-rate trend from T0 to T2 in control and treated groups. *P<0.05.
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the Neonatal Facial Coding System to assess pain reactions 
and reported any difference between sucrose administration 
and breast-feeding on cortical activity measured by NIRS 
during a painful procedure. Stevens et al reported that 
sucrose was effective to treat pain associated with a single 
heel lance in term neonates admitted to tertiary NICUs.10 
Efe et al studied three random groups (sucrose, breast-
feeding, and control) of term newborn infants at 48 hours 
of life and found similar pain responses in the sucrose and 
breast-feeding groups using the NIPS. They also reported 
that newborns given sucrose spent less time crying than 
breast-fed newborns.16
Thakkar et al demonstrated that sucrose in combination 
with NNS was more effective than sucrose alone in con-
trolling pain in full-term newborns undergoing heel-stick 
procedures in the first hours of life,3 and this finding led us 
to evaluate its effect in a population of newborns over the 
first week of life. No studies have reported data regarding the 
efficacy of 24% sucrose for analgesia in healthy newborns 
over the first week of life.
Figure 3 SpO2 trend from T0 to T2 in control and treated groups. *P<0.05.
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Figure 4 Neonatal Infant Pain Scale (NIPS) scores from T0 to T2 in control group and treated group.
Notes: Dashed line points out the threshold of the pain. A score ≥4 indicates pain. *P<0.05.
7
*
6
5
4
3
2
1
0
T0 T1 T2
Time
Control group
Treated group
N
IP
S 
sc
or
e 
(m
ed
ia
n)
Journal of Pain Research 2019:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
304
De Bernardo et al
Our results may represent one of the most important 
future perspectives in this field, evaluating the efficacy of 
oral 24% sucrose for complete analgesia in term infants 
over time. Few studies have evaluated HR and SpO
2
 
responses after noxious stimulation in term infants beyond 
the NICU setting. The use of HR and SpO
2
 as outcome 
measures and the evidence that a proper analgesic pro-
cedure can protect patients from pain-related variation in 
vital parameters represents the second main finding of our 
paper as these physiological responses to pain objectify 
recognition and care of pain during unpleasant experiences. 
Furthermore, the fact that changes in HR and SpO
2
 are 
not significant in infants treated with 24% sucrose even 
after 1 minute from venipuncture demonstrates a possible 
protective effect from repercussions subsequent to the 
pain stimulus.17
Previously, we found that sensorial saturation, a non-
invasive, easily performed, and reproducible technique, 
was effective for analgesia during heel prick in neonates.6 
During sensorial saturation, mothers simultaneously 
attract their infant’s attention by massaging the cheek, 
speaking to the baby gently, and administering 1 mL 
10% oral glucose.6 There is evidence that sweet solutions 
<18% are  ineffective in reducing infant pain optimally.10 
In this study, we used 24% sucrose associated with NNS 
to control pain, and we verify complete analgesia through 
a reduction in pain-related variations in HR and SpO
2
 in 
term newborns.
This study has some limitations. It did not include a 
control group receiving a placebo (sterile water). However, 
to assign infants randomly to a placebo and deny them a 
treatment would have been unethical. The small sample size 
does not allow us to reach conclusive results, but the findings 
are significant and pave the way to widespread use of sucrose 
24% associated with NNS.
In conclusion, 1 mL 24% oral sucrose with NNS prior to 
and during venipuncture is a noninvasive, adequately safe, 
and reproducible tool for complete analgesia in healthy term 
newborns over the first week of life. It also protects against 
pain-related variations in HR and SpO
2
. Replication of this 
study in a large trial is needed to implement coverage of 
pain control in babies. New research will address barriers to 
scaling up and evaluate 24% sucrose efficacy immediately 
after birth at the time of intramuscular injection of vitamin 
K for vitamin K deficiency-related bleeding prophylaxis and 
beyond the neonatal period.
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